| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $1,617,572 | -8,927 | -0.14% | $181.20 | 6,277,946 | 17 Jun 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $227,522 | -1,261 | -0.02% | $180.43 | 6,276,685 | 18 Jun 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.405. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.97. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |